HYDERABAD (Reuters) – India’s Dr Reddy’s on Tuesday said that its research and development centre in Hyderabad is being inspected by the U.S. Food and Drug Administration.
“We confirm the commencement of a USFDA inspection at our R&D centre (Integrated Product Development Organisation or IPDO),” a Reddy’s spokesperson told Reuters.
(Reporting by Rishika Sadam in Hyderabad; Editing by Sonia Cheema)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content.